A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
Clinical trial NCT06442436 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06442436
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2026-09-14
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.